Modified herpes virus treatment proving effective in fighting cancer

June 22, 2018

Source: New York Daily News
Author: Ariel Scotti
Published: June 22, 2018

Medical oncologists are utilizing an FDA-approved treatment called talimogene laherparepvec (T-VEC) therapy to fight melanoma.

Dr. Alan Tan applies T-VEC, an oncolytic virus, directly to melanoma lesions. The genetically modified herpes virus is used to infect the cancer cells and make it more recognizable to the immune system.

Read the full story here